First-line (1L) immuno-oncology (10) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

被引：2
|
作者：
Dudani, Shaan
Graham, Jeffrey
Wells, Connor
Pal, Sumanta K.
Dizman, Nazli
Donskov, Frede
Bjarnason, Georg A.
Hansen, Aaron Richard
Iafolla, Marco Adelmo James
Vaishampayan, Ulka N.
Porta, Camillo
Beuselinck, Benoit
Yan, Flora
Wood, Lori
Liow, Elizabeth Chien Hern
Kollmannsberger, Christian K.
Yuasa, Takeshi
Zhang, Chiyuan A.
Choueiri, Toni K.
Heng, Daniel Yick Chin
机构：
[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[2] Univ Manitoba, Winnipeg, MB, Canada
[3] City Hope Natl Med Ctr, Duarte, CA USA
[4] City Hope Comprehens Canc Ctr, Duarte, CA USA
[5] Aarhus Univ Hosp, Aarhus, Denmark
[6] Sunnybrook Res Inst, Toronto, ON, Canada
[7] Princess Margaret Canc Ctr, Toronto, ON, Canada
[8] Univ Alberta, Edmonton, AB, Canada
[9] Karmanos Canc Inst, Detroit, MI USA
[10] Univ Pavia, Pavia, Italy
[11] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium
[12] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[13] Dalhousie Univ, Halifax, NS, Canada
[14] Eastern Hlth, Melbourne, Vic, Australia
[15] Univ British Columbia, Vancouver, BC, Canada
[16] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[17] Stanford Hosp, Stanford, CA USA
[18] Dana Farber Canc Inst, Boston, MA 02115 USA
[19] Univ Calgary, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
584
引用
收藏
页数：2
相关论文
共 50 条
  • [1] First-line (1L) immuno-oncology (10) combination therapies in metastatic renal-cell carcinoma (mRCC): Results from the international mRCC database consortium (IMDC).
    Dudani, Shaan
    Graham, Jeffrey
    Wells, Connor
    Bakouny, Ziad
    Pal, Sumanta K.
    Dizman, Nazli
    Donskov, Frede
    Porta, Camillo
    de Velasco, Guillermo
    Hansen, Aaron Richard
    Iafolla, Marco Adelmo James
    Beuselinck, Benoit
    Vaishampayan, Ulka N.
    Wood, Lori
    Liow, Elizabeth Chien Hern
    Yan, Flora
    Yuasa, Takeshi
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Outcomes of first-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
    Gan, Chun Loo
    Dudani, Shaan
    Wells, Connor J.
    Schmidt, Andrew Lachlan
    Bakouny, Ziad
    Szabados, Bernadett
    Parnis, Francis
    Wong, Shirley
    Lee, Jae-Lyun
    de Velasco, Guillermo
    Pal, Sumanta K.
    Davis, Ian D.
    Kanesvaran, Ravindran
    Wood, Lori
    Kollmannsberger, Christian K.
    McKay, Rana R.
    Beuselinck, Benoit
    Donskov, Frede
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [3] Predictors of objective response to first-line immuno-oncology combination therapies in metastatic renal cell carcinoma: Results from the international metastatic renal cell database consortium (IMDC).
    Navani, Vishal
    Ernst, Matthew Scott
    Wells, Connor
    Yuasa, Takeshi
    Takemura, Kosuke
    Donskov, Frede
    Basappa, Naveen S.
    Schmidt, Andrew Lachlan
    Pal, Sumanta K.
    Meza, Luis A.
    Wood, Lori
    Ernst, D. Scott
    Szabados, Bernadett
    McKay, Rana R.
    Weickhardt, Andrew James
    Suarez, Cristina
    Kapoor, Anil
    Lee, Jae-Lyun
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [4] The impact of impaired renal function on the effectiveness of first-line immuno-oncology combination therapies in metastatic renal cell carcinoma (mRCC): Results from the international metastatic RCC database consortium (IMDC)
    Navani, V.
    Ernst, M. S.
    Takemura, K.
    Pal, S. K.
    Powles, T. B.
    Donskov, F.
    Wells, J. C.
    Kollmannsberger, C. K.
    Beuselinck, B.
    Alva, A. S.
    Weickhardt, A. J.
    Lalani, A-K.
    Ernst, D. S.
    Agarwal, N.
    Choueiri, T. K.
    Heng, D. Y. C.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1215 - S1216
  • [5] First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium
    Dudani, Shaan
    Graham, Jeffrey
    Wells, J. Connor
    Bakouny, Ziad
    Pal, Sumanta K.
    Dizman, Nazli
    Donskov, Frede
    Porta, Camillo
    de Velasco, Guillermo
    Hansen, Aaron
    Iafolla, Marco
    Beuselinck, Benoit
    Vaishampayan, Ulka N.
    Woodk, Lori A.
    Liow, Elizabeth
    Yan, Flora
    Yuasa, Takeshi
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    [J]. EUROPEAN UROLOGY, 2019, 76 (06) : 861 - 867
  • [6] Impact of smoking status (SS) on the clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with first line (1L) immuno-oncology (IO)-combination regimens: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Gebrael, Georges
    Saad, Eddy
    Labaki, Chris
    Saliby, Renee Maria
    Sayegh, Nicolas
    Wells, J. Connor
    Semaan, Karl
    Eid, Marc
    Takemura, Kosuke
    Ernst, Matthew Scott
    Lemelin, Audreylie
    Basappa, Naveen S.
    Wood, Lori
    Powles, Thomas
    Ernst, D. Scott
    Kapoor, Anil
    Xie, Wanling
    Agarwal, Neeraj
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Morales, Jose Manuel Ruiz
    Wells, J. Connor
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Knox, Jennifer J.
    Beuselinck, Benoit
    Vaishampayan, Ulka N.
    Brugarolas, James
    Broom, Reuben James
    Bamias, Aristotelis
    Yuasa, Takeshi
    Srinivas, Sandhya
    Ernst, D. Scott
    Pezaro, Carmel Jo
    Wood, Lori
    Kollmannsberger, Christian K.
    Rini, Brian I.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [8] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the international metastatic renal cell carcinoma database consortium (IMDC).
    Morales, Jose Manuel Ruiz
    Swierkowski, Marcin
    Wells, Connor
    Fraccon, Anna Paola
    La Russa, Francesca
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Sim, Hao-Wen
    Beuselinck, Benoit
    Wood, Lori
    Yuasa, Takeshi
    Pezaro, Carmel Jo
    Rini, Brian I.
    Szczylik, Cezary
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Roussel, Eduard
    Kinget, Lisa
    Beuselinck, Benoit
    Albersen, Maarten
    Wells, Connor
    Ernst, Matthew Scott
    Donskov, Frede
    Schmidt, Andrew Lachlan
    Szabados, Bernadett
    Pal, Sumanta K.
    Meza, Luis A.
    Agarwal, Neeraj
    Weickhardt, Andrew James
    Davis, Ian D.
    Alva, Ajjai Shivaram
    Wood, Lori
    Porta, Camillo
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    Navani, Vishal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [10] Characterization of patients with metastatic renal cell carcinoma achieving complete response to first-line therapies: Results from the international metastatic renal cell carcinoma database consortium (IMDC)
    Takemura, K.
    Navani, V.
    Ernst, M. S.
    Wells, J. C.
    Choueiri, T. K.
    Meza, L.
    Pal, S. K.
    Lee, J-L.
    Li, H.
    Agarwal, N.
    Alva, A. S.
    Hansen, A. R.
    Basappa, N. S.
    Szabados, B. E.
    Powles, T. B.
    Tran, B.
    Hocking, C. M.
    Beuselinck, B.
    Yuasa, T.
    Heng, D. Y. C.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1209 - S1210
12345